Financhill
Back

AnGes, Inc. 10K Form

Sell
28

AMGXF
AnGes, Inc.

Last Price:
$0.36
Seasonality Move:
-16.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMGXF News And Ratings

See the #1 stock for the next 7 days that we like better than AMGXF

AMGXF Financial Statistics

Sales & Book Value

Annual Sales: $4.2M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.07
Price / Book: 4.92

Profitability

EPS (TTM): -0.57540
Net Income (TTM): $-169.5M
Gross Margin: $-20.4M
Return on Equity: -349.76%
Return on Assets: -258.28%

AnGes, Inc. Earnings Forecast

Key AnGes, Inc. Financial Ratios

  • The Gross Profit Margin over the past 25 years for AMGXF is -479.95%.
  • The Selling, General & Administrative Expenses for AMGXF have been equal to 828.42% of Gross Profit Margin.
  • The Research & Development expenses have been 585.62% of Revenue.
  • The Net Earning history of AMGXF is -4,370.29% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 11 years.

AnGes, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AMGXF
Website: anges.co.jp

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 2.36
Quick Ratio: 1.55

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AMGXF Technical Analysis vs Fundamental Analysis

Sell
28
AnGes, Inc. (AMGXF) is a Sell

Is AnGes, Inc. a Buy or a Sell?

  • AnGes, Inc. stock is rated a Sell
    The current AnGes, Inc. [AMGXF] share price is $0.36. The Score for AMGXF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.